Article
AAV9-Mediated Expression of SMN Restricted to Neurons Does Not Rescue the Spinal Muscular Atrophy Phenotype in Mice.
Molecular therapy : the journal of the American Society of Gene Therapy - 5 Aug 2020
Besse Aurore, Astord Stephanie, Marais Thibaut, Roda Marianne, Giroux Benoit, Lejeune François-Xavier, Relaix Frederic, Smeriglio Piera, Barkats Martine, Biferi Maria Grazia
Abstract excerpt
Spinal muscular atrophy (SMA) is a neuromuscular disease mainly caused by mutations or deletions in the survival of motor neuron 1 (SMN1) gene and characterized by the degeneration of motor neurons and progressive muscle weakness. A viable therapeutic approach for SMA patients is a gene replacement strategy that restores functional SMN expression using adeno-associated virus serotype 9 (AAV9) vectors. Currently,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
